Biophytis (EPA:ALBPS)

BRIEF

published on 06/25/2024 at 23:05, 1 year 7 months ago

Biophytis Approves All Resolutions at General Meeting

Shareholders Biophytis General Meeting Resolutions
REGULATED PRESS RELEASE

published on 06/25/2024 at 23:00, 1 year 7 months ago

RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024
Biophytis SA announces the approval of all resolutions at the combined general meeting held on June 24, 2024, with significant shareholder participation

Shareholders General Meeting Resolutions Approval Biophytis SA
BRIEF

published on 06/20/2024 at 07:05, 1 year 7 months ago

Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at Up to €108 Million

Biophytis Pharmaceuticals Latin America BIO101 Blanver
PRESS RELEASE

published on 06/20/2024 at 07:00, 1 year 7 months ago

Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 million. Agreement includes upfront and milestones payments, double-digit royalties, and collaboration on manufacturing and clinical development

Biophytis Latin America Exclusive Rights Blanver Pharmaceutical Deal
REGULATED PRESS RELEASE

published on 06/20/2024 at 07:00, 1 year 7 months ago

Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million. Collaboration for commercialization and clinical development announced

Biophytis Latin America BIO101 Exclusive Rights Blanver
BRIEF

published on 06/20/2024 at 01:15, 1 year 7 months ago

Biophytis extends its contract with Atlas to finance its clinical activities

Biophytis Biotechnology Convertible Bonds Funding Atlas
PRESS RELEASE

published on 06/20/2024 at 01:10, 1 year 7 months ago

Biophytis extends its contract with Atlas to secure financing for its business activities
Biophytis extends financing agreement with Atlas, ensures funding for clinical programs OBA in obesity and MYODA in DMD. Details on the contract amendment and risk factors

Biophytis Atlas Financing Agreement Clinical Programs Risk Factors
BRIEF

published on 06/19/2024 at 23:05, 1 year 7 months ago

Biophytis Extends Financing Contract with Atlas

Biophytis Biotechnology Financing Clinical Trials Atlas
REGULATED PRESS RELEASE

published on 06/19/2024 at 23:00, 1 year 7 months ago

Biophytis extends its contract with Atlas to secure financing for its business activities
Biophytis extends bond financing agreement with Atlas, securing funding for clinical programs in obesity and Duchenne Muscular Dystrophy. Terms reflect confidence in growth potential

Biophytis Atlas Growth Potential Clinical Programs Bond Financing Agreement
BRIEF

published on 06/12/2024 at 10:16, 1 year 7 months ago

Biophytis announces the success of the industrial transfer of production of BIO101

Biophytis Biotechnology Duchenne Muscular Dystrophy BIO101 Seqens

Published on 01/31/2026 at 03:15, 8 hours 40 minutes ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 9 hours 35 minutes ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 10 hours 15 minutes ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 11 hours 55 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 12 hours 55 minutes ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 02:45, 9 hours 9 minutes ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 13 hours 54 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 15 hours 44 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 15 hours 45 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 15 hours 47 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches

View all EQS

Published on 01/30/2026 at 17:45, 18 hours 10 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 1 day 3 hours ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 1 day 17 hours ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 18 hours ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 18 hours ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

News